K. Aho, M. Heliovaara, J. Maatela, T. Tuomi, and T. Palosuo, Rheumatoid factors antedating clinical rheumatoid arthritis, J. Rheumatol, 1991.

Y. Aikawa, K. Morimoto, T. Yamamoto, H. Chaki, A. Hashiramoto et al., Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1, Nat. Biotechnol, vol.26, pp.817-823, 2008.

A. Alghasham and Z. Rasheed, Therapeutic targets for rheumatoid arthritis: Progress and promises, 2014.
DOI : 10.3109/08916934.2013.873413

, Report of the American College of Rheumatology Pain Management Task Force, Arthritis Care Res. (Hoboken), vol.62, pp.590-599, 2010.

R. S. Barreto, J. S. Quintans, R. S. Amarante, T. S. Nascimento, R. S. Amarante et al., Evidence for the involvement of TNF-? and IL-1? in the antinociceptive and anti-inflammatory activity of Stachys lavandulifolia Vahl. (Lamiaceae) essential oil and (-)-?-bisabolol, its main compound, in mice, J. Ethnopharmacol, vol.191, pp.9-18, 2016.

,

A. Bendele, J. Mccomb, T. Gould, T. Mcabee, G. Sennello et al., Animal models of arthritis: relevance to human disease, Toxicol. Pathol, 1999.
DOI : 10.1177/019262339902700125

L. Bevaart, M. J. Vervoordeldonk, and P. P. Tak, Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis?, Arthritis Rheum, 2010.

C. Bogdan, Nitric oxide and the immune response, Nat. Immunol, 2001.

A. M. Brinker, J. Ma, P. E. Lipsky, and I. Raskin, Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae), Phytochemistry, 2007.

R. G. Brito, A. A. Araújo, J. S. Quintans, K. A. Sluka, and L. J. Quintans-júnior, Enhanced analgesic activity by cyclodextrins-a systematic review and meta-analysis, Expert Opin. Drug Deliv, 2015.
DOI : 10.1517/17425247.2015.1046835

T. A. Butterfield, T. M. Best, and M. A. Merrick, The dual roles of neutrophils and macrophages in inflammation: A critical balance between tissue damage and repair, J. Athl. Train, pp.79217-79218, 2006.

R. Cascão, B. Vidal, H. Raquel, A. Neves-costa, N. Figueiredo et al., Effective treatment of rat adjuvant-induced arthritis by celastrol, Autoimmun. Rev, vol.11, pp.856-862, 2012.

G. Casey, Arthritis: joints inflamed, Nurs. N. Z, vol.21, pp.20-24, 2015.

A. I. Catrina, J. Ytterberg, A. Reynisdottir, G. Malmström, V. Klareskog et al., Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis, Nat. Rev. Rheumatol, 2014.
DOI : 10.1038/nrrheum.2014.115

J. Y. Chen, H. Wu, H. Li, S. L. Hu, M. M. Dai et al., Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis, Int. Immunopharmacol, vol.24, pp.102-109, 2015.

L. Chen, Z. Lan, S. Ma, L. Zhao, and X. Yang, Attenuation of gouty arthritis by emodinol in monosodium urate crystal-treated mice, Planta Med, vol.79, pp.634-638, 2013.

H. S. Cheung, Crystal/cell interactions in osteoarthritis, Curr. Opin. Orthop, vol.17, pp.424-428, 2006.
DOI : 10.1097/01.bco.0000244033.09671.38

H. Chong, H. G. Vikis, and K. Guan, Mechanisms of regulating the Raf kinase family, Cell. Signal, 2003.

N. Choudhary, L. K. Bhatt, and K. S. Prabhavalkar, Experimental animal models for rheumatoid arthritis, Immunopharmacol. Immunotoxicol, vol.40, pp.193-200, 2018.
DOI : 10.1080/08923973.2018.1434793

,

S. Chu, S. Yang, K. Lue, Y. Hsieh, T. Hsiao et al., The clinical significance of gelatinase B in gouty arthritis of the knee, Clin. Chim. Acta, vol.339, pp.77-83, 2004.

L. G. Darlington and T. W. Stone, Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders, Br. J. Nutr, 2001.

B. G. Darnay, J. Ni, P. A. Moore, and B. B. Aggarwal, Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaBinducing kinase. Identification of a novel TRAF6 interaction motif, J. Biol. Chem, vol.274, pp.7724-7755, 1999.
DOI : 10.1074/jbc.274.12.7724
URL : http://www.jbc.org/content/274/12/7724.full.pdf

M. T. De-santana-souza, J. R. Almeida, S. Da, A. A. De-souza-araujo, M. C. Duarte et al., StructureActivity Relationship of Terpenes with Anti-Inflammatory Profile-A Systematic Review, Basic Clin. Pharmacol. Toxicol, vol.115, pp.244-256, 2014.

,

R. J. Desai, J. K. Rao, R. A. Hansen, G. Fang, M. L. Maciejewski et al., Predictors of treatment initiation with tumor necrosis factor-? inhibitors in patients with rheumatoid arthritis, J. Manag. Care Pharm, 2014.

D. Paola, R. Cuzzocrea, and S. , Predictivity and sensitivity of animal models of arthritis, Autoimmun. Rev, 2008.

C. A. Dinarello, Proinflammatory cytokines, 2000.

R. C. Dutra, . Simão-da, K. A. Silva, A. F. Bento, R. Marcon et al., Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: The involvement of cannabinoid system, Neuropharmacology, vol.63, pp.593-605, 2012.

,

M. Endale, W. M. Lee, Y. S. Kwak, N. M. Kim, B. K. Kim et al., Torilin ameliorates type II collageninduced arthritis in mouse model of rheumatoid arthritis, Int. Immunopharmacol, vol.16, pp.232-242, 2013.

H. W. Fan, G. Y. Liu, C. F. Zhao, X. F. Li, and X. Y. Yang, Differential expression of COX-2 in osteoarthritis and rheumatoid arthritis, Genet. Mol. Res, 2015.

M. Feldmann, Many cytokines are very useful therapeutic targets in disease, J. Clin. Invest, 2008.

Z. Feng, X. Li, J. Lin, W. Zheng, Z. Hu et al., Oleuropein inhibits the IL-1?-induced expression of inflammatory mediators by suppressing the activation of NF-?B and MAPKs in human osteoarthritis chondrocytes, 2017.

C. Figueiredo, J. Barroso, L. Pedro, and J. Scheefeer, Factors affecting secondary metabolite production in plants: volatile components and essential oils. Flavour Fragr, 2007.

G. S. Firestein, Evolving concepts of rheumatoid arthritis, Nature, vol.423, pp.356-361, 2003.

S. Fukumitsu, M. O. Villareal, T. Fujitsuka, K. Aida, and H. Isoda, Anti-inflammatory and anti-arthritic effects of pentacyclic triterpenoids maslinic acid through NF-?B inactivation, Mol. Nutr. Food Res, vol.60, pp.399-409, 2016.

C. Gabay, Cytokine inhibitors in the treatment of rheumatoid arthritis, Expert Opin. Biol. Ther, vol.2, pp.135-149, 2002.

B. I. Gavril?, C. Ciofu, and V. Stoica, Biomarkers in Rheumatoid Arthritis, what is new?, J. Med. Life, 2016.

M. C. Genovese, J. D. Mckay, E. L. Nasonov, E. F. Mysler, N. Da-silva et al., Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug the, Arthritis Rheum, 2008.

V. Gilston, H. W. Jones, C. C. Soo, A. Coumbe, S. Blades et al., NF-kappa B activation in human kneejoint synovial tissue during the early stage of joint inflammation, Biochem. Soc. Trans. 25, p.518, 1997.

B. Görtz, S. Hayer, B. Tuerck, J. Zwerina, J. S. Smolen et al., Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo, Arthritis Res. Ther, vol.7, 2005.

D. N. Gouveia, L. T. Pina, T. K. Rabelo, W. B. Da-rocha-santos, J. S. Quintans et al., Monoterpenes as Perspective to Chronic Pain Management: A Systematic Review, Curr. Drug Targets, vol.19, pp.960-972, 2018.

,

A. G. Guimarães, J. S. Quintans, and L. J. Quintans-júnior, Monoterpenes with analgesic activity-A systematic review, Phyther. Res, 2013.

A. G. Guimarães, M. R. Serafini, and L. J. Quintans-júnior, Terpenes and derivatives as a new perspective for pain treatment: a patent review, Expert Opin. Ther. Pat, vol.24, pp.243-65, 2014.

Z. Han, D. L. Boyle, M. Manning, and G. S. Firestein, AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis, 1998.

J. M. Hazes and J. J. Luime, The epidemiology of early inflammatory arthritis, Nat. Rev. Rheumatol, vol.7, pp.381-390, 2011.

T. Heiberg, A. Finset, T. Uhlig, and T. K. Kvien, Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis, Ann. Rheum. Dis, 2005.

S. Hopson, K. Saverno, L. Z. Liu, A. Al-sabbagh, J. Orazem et al., Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis, J. Manag. Care Spec. Pharm, 2016.

M. Huang, J. Lu, M. Huang, J. Bao, X. Chen et al., Terpenoids: natural products for cancer therapy, Expert Opin. Investig. Drugs, 2012.

Y. Itoh, Metalloproteinases: potential therapeutic targets for rheumatoid arthritis, Endocr. Metab. Immune Disord. Drug Targets, 2015.

Y. H. Jean, W. F. Chen, C. Y. Duh, S. Y. Huang, C. H. Hsu et al., Inducible nitric oxide synthase and cyclooxygenase-2 participate in anti-inflammatory and analgesic effects of the natural marine compound lemnalol from Formosan soft coral Lemnalia cervicorni, Eur. J. Pharmacol, 2008.

S. Kang, S. Yoon, D. Roh, M. Jeon, H. Seo et al., The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models, J. Pharm. Pharmacol, vol.60, pp.1347-1354, 2008.

K. Kannan, R. A. Ortmann, and D. Kimpel, Animal models of rheumatoid arthritis and their relevance to human disease, Pathophysiology, vol.12, pp.167-81, 2005.

,

D. Kashyap, A. Sharma, H. S. Tuli, S. Punia, and A. K. Sharma, Ursolic Acid and Oleanolic Acid: Pentacyclic Terpenoids with Promising Anti-Inflammatory Activities. Recent Pat. Inflamm, Allergy Drug Discov, 2016.

S. Khalifé and M. Zafarullah, Molecular targets of natural health products in arthritis, Arthritis Res. Ther, vol.13, 2011.

H. Kikuchi, T. Manda, K. Kobayashi, Y. Yamada, and K. Iguchi, Anti-tumor activity of lemnalol isolated from the soft coral Lemnalia tenuis Verseveldt, Chem. Pharm. Bull. (Tokyo), vol.31, pp.1086-1094, 1983.

C. H. Kim, Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system, Exp. Hematol, 2006.

B. W. Kirkham, M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird et al., Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort), Arthritis Rheum, vol.54, pp.1122-1153, 2006.

L. Klareskog, L. Padyukov, J. Lorentzen, and L. Alfredsson, Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis, Nat. Clin. Pract. Rheumatol, vol.2, pp.425-433, 2006.

K. Krishnan, L. E. Mathew, N. R. Vijayalakshmi, and A. Helen, Anti-inflammatory potential of ?-amyrin, a triterpenoid isolated from Costus igneus, 2014.

T. Lazarevi?-pasti, A. Leskovac, and V. Vasi?, Myeloperoxidase Inhibitors as Potential Drugs, Curr. Drug Metab, 2015.

H. P. Lee, S. Y. Huang, Y. Y. Lin, H. M. Wang, Y. H. Jean et al., Soft coral-derived lemnalol alleviates monosodium urate-induced gouty arthritis in rats by inhibiting leukocyte infiltration and iNOS, COX-2 and c-Fos protein expression, Mar. Drugs, vol.11, pp.99-113, 2013.

J. Lee, S. Baek, J. Lee, J. Lee, D. G. Lee et al., Digoxin ameliorates autoimmune arthritis via suppression of Th17 differentiation, Int. Immunopharmacol, vol.26, pp.103-111, 2015.

J. C. Lee, J. T. Laydon, P. C. Mcdonnell, T. F. Gallagher, S. Kumar et al., A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, 1994.

Y. C. Lee, Effect and treatment of chronic pain in inflammatory arthritis, Curr. Rheumatol. Rep, vol.15, 2013.

Y. Y. Leung, J. L. Huebner, B. Haaland, S. B. Wong, and V. B. Kraus, Synovial fluid pro-inflammatory profile differs according to the characteristics of knee pain, Osteoarthr. Cartil, 2017.

H. Li, X. Gong, L. Zhang, Z. Zhang, F. Luo et al., Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice, Phytomedicine, vol.16, pp.538-546, 2009.

J. Li, X. Zhang, and H. Huang, Protective effect of linalool against lipopolysaccharide/dgalactosamine-induced liver injury in mice, Int. Immunopharmacol, 2014.

X. Li, C. Jiang, and W. Zhu, Crocin reduces the inflammation response in rheumatoid arthritis, Biosci. Biotechnol. Biochem, vol.81, pp.891-898, 2017.

,

M. D. Lima, L. J. Quintans-júnior, W. A. De-santana, C. Martins-kaneto, M. B. Pereira-soares et al., Anti-inflammatory effects of carvacrol: Evidence for a key role of interleukin-10, Eur. J. Pharmacol, vol.699, 2013.

L. Liu, Y. Hua, D. Wang, L. Shan, Y. Zhang et al., A Sesquiterpene Lactone from a Medicinal Herb Inhibits Proinflammatory Activity of TNF-? by Inhibiting Ubiquitin-Conjugating Enzyme UbcH5, Chem. Biol, vol.21, pp.1341-1350, 2014.

Q. Liu, J. Zhao, R. Tan, H. Zhou, Z. Lin et al., Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model, Scand. J. Rheumatol, vol.44, pp.182-191, 2015.

V. Loria, I. Dato, F. Graziani, and L. M. Biasucci, Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes, 2008.

Y. Lu, J. Xiao, Z. W. Wu, Z. M. Wang, J. Hu et al., Kirenol exerts a potent anti-arthritic effect in collagen-induced arthritis by modifying the T cells balance, Phytomedicine, vol.19, pp.882-889, 2012.

,

E. Lubberts, M. I. Koenders, B. Oppers-walgreen, L. Van-den-bersselaar, C. J. Coenen-de-roo et al., Treatment with a Neutralizing AntiMurine Interleukin-17 Antibody after the Onset of Collagen-Induced Arthritis Reduces Joint Inflammation, Cartilage Destruction, and Bone Erosion, Arthritis Rheum, 2004.

Y. Lv, L. Zhang, N. Li, N. Mai, Y. Zhang et al., Geraniol promotes functional recovery and attenuates neuropathic pain in rats with spinal cord injury. Can, J. Physiol. Pharmacol, vol.95, pp.1389-1395, 2017.

Q. Ma and J. Jiang, Functional Components from Nature-Derived Drugs for the Treatment of Rheumatoid Arthritis, Curr. Drug Targets, vol.17, pp.1673-1686, 2016.

X. Ma, Y. Liu, Y. Zhang, X. Yu, W. Wang et al., Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-?B and MAPK signaling pathways, Biochem. Biophys. Res. Commun, 2014.

S. S. Makarov, NF-??B in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction, Arthritis Res, 2001.

G. M. Mccarthy, J. A. Augustine, A. S. Baldwin, P. A. Christopherson, H. S. Cheung et al., Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein 1, and protein kinase c, J. Biol. Chem, vol.273, pp.35161-35170, 1998.

I. B. Mcinnes and G. Schett, Cytokines in the pathogenesis of rheumatoid arthritis, Nat. Rev. Immunol, 2007.

K. Mcnamee, R. Williams, and M. Seed, Animal models of rheumatoid arthritis: How informative are they?, Eur. J. Pharmacol, 2015.

P. Miossec, Interleukin-17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergy, Arthritis Rheum, 2003.
DOI : 10.1002/art.10816
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.10816

K. D. Moudgil, P. Kim, and E. Brahn, Advances in rheumatoid arthritis animal models, Curr. Rheumatol. Rep, vol.13, pp.456-463, 2011.
DOI : 10.1007/s11926-011-0200-z
URL : http://europepmc.org/articles/pmc3786133?pdf=render

S. M. Nanjundaiah, S. H. Venkatesha, H. Yu, L. Tong, J. P. Stains et al., Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk, J. Biol. Chem, vol.287, pp.22216-22226, 2012.
DOI : 10.1074/jbc.m112.356816
URL : http://www.jbc.org/content/287/26/22216.full.pdf

S. S. Nascimento, E. A. Camargo, J. M. Desantana, A. A. Araújo, P. P. Menezes et al., Linalool and linalool complexed in ?-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia, Naunyn. Schmiedebergs. Arch. Pharmacol, vol.387, pp.935-942, 2014.
DOI : 10.1007/s00210-014-1007-z

, No Title, Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults, 2009.

E. O'neill and W. Kolch, Conferring specificity on the ubiquitous Raf/MEK signalling pathway, Br. J. Cancer, vol.90, pp.283-291, 2004.

H. Pae, G. Jeong, H. Kim, W. H. Woo, H. Y. Rhew et al., Costunolide inhibits production of tumor necrosis factoralpha and interleukin-6 by inducing heme oxygenase-1 in RAW264.7 macrophages, Inflamm. Res, 2007.

E. M. Paleolog, Angiogenesis in rheumatoid arthritis, Arthritis Res, vol.4, 2002.

R. Pan, Y. Dai, X. Gao, and Y. Xia, Scopolin isolated from Erycibe obtusifolia Benth stems suppresses adjuvant-induced rat arthritis by inhibiting inflammation and angiogenesis, Int. Immunopharmacol, 2009.
DOI : 10.1016/j.intimp.2009.02.019

M. Phillipson and P. Kubes, The neutrophil in vascular inflammation, Nat. Med, 2011.
DOI : 10.1038/nm.2514

A. C. Piccinelli, J. A. Santos, E. C. Konkiewitz, S. A. Oesterreich, A. S. Formagio et al., Antihyperalgesic and antidepressive actions of (R)(+)-limonene, ?-phellandrene, and essential oil from Schinus terebinthifolius fruits in a neuropathic pain model, Nutr. Neurosci, vol.18, pp.217-224, 2015.

,

L. J. Quintans-júnior, A. A. Araújo, R. G. Brito, P. L. Santos, J. S. Quintans et al., ?-caryophyllene, a dietary cannabinoid, complexed with ?-cyclodextrin produced anti-hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn, Life Sciences. Elsevier B, 2016.

L. J. Quintans-júnior, M. T. Santana, M. S. Melo, D. P. De-sousa, I. S. Santos et al., Antinociceptive and anti-inflammatory effects of Costus spicatus in experimental animals, Pharm. Biol, vol.48, pp.1097-1102, 2010.

N. Riaz, I. Anis, M. Aziz-ur-rehman, A. Ahmed, Z. Muhammad et al., Emodinol, ?-glucuronidase inhibiting triterpene from Paeonia emodi, Nat. Prod. Res, 2003.
DOI : 10.1080/1057563021000060103

N. F. Rocha, E. R. Rios, A. M. Carvalho, G. S. Cerqueira, A. D. Lopes et al., Anti-nociceptive and anti-inflammatory activities of (-)-?-bisabolol in rodents, Naunyn. Schmiedebergs. Arch. Pharmacol, vol.384, pp.525-533, 2011.

E. Röhner, G. Matziolis, C. Perka, B. Füchtmeier, T. Gaber et al., Inflammatory synovial fluid microenvironment drives primary human chondrocytes to actively take part in inflammatory joint diseases, Immunol. Res, 2012.

D. O. Salinas-sánchez, A. Zamilpa, S. Pérez, M. Herrera-ruiz, J. Tortoriello et al., Effect of Hautriwaic Acid Isolated from Dodonaea viscosa in a Model of Kaolin/Carrageenan-Induced Monoarthritis, Planta Med, vol.81, pp.1240-1247, 2015.

S. Sánchez-fidalgo, I. Villegas, M. Á. Rosillo, M. Aparicio-soto, and C. A. De-la-lastra, Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways, Mol. Nutr. Food Res, 2015.

P. L. Santos, R. G. Brito, J. P. Matos, J. S. Quintans, and L. J. Quintans-júnior, Fos Protein as a Marker of Neuronal Activity: a Useful Tool in the Study of the Mechanism of Action of Natural Products with Analgesic Activity, Mol. Neurobiol, 2017.

S. Saravanan, V. I. Islam, N. Prakash-babu, P. Pandikumar, K. Thirugnanasambantham et al., Swertiamarin attenuates inflammation mediators via modulating NF-?B/I ?b and JAK2/STAT3 transcription factors in adjuvant induced arthritis, Eur. J. Pharm. Sci, vol.56, pp.70-86, 2014.

J. F. Sarmento-neto, L. G. Do-nascimento, C. F. Felipe, and D. P. De-sousa, Analgesic potential of essential oils, 2016.

U. Schlieer, M. Streitz, and B. Sawitzki, Tregs. Curr. Opin. Organ Transplant, 2012.

K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer et al., Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl. Acad. Sci, 1994.

G. S. Selders, A. E. Fetz, M. Z. Radic, and G. L. Bowlin, An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration, Regen. Biomater, 2017.

S. Shiozawa, K. Shimizu, K. Tanaka, and K. Hino, Studies on the Contribution of cfos/AP-1 to Arthritic Joint Destruction, J. Clin. Invest, 1997.

S. Siebert, A. Tsoukas, J. Robertson, and I. Mcinnes, Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases, Pharmacol. Rev, vol.67, pp.280-309, 2015.

J. A. Singh, R. Christensen, G. A. Wells, M. E. Suarez-almazor, R. Buchbinder et al., Biologics for rheumatoid arthritis: An overview of Cochrane reviews, Sao Paulo Med. J, 2010.

S. J. Snelling, S. Bas, G. J. Puskas, S. G. Dakin, D. Suva et al., Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype, PLoS One, 2017.

M. Stolina, G. Schett, D. Dwyer, S. Vonderfecht, S. Middleton et al., RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNF? or anti-IL-1 therapies, Arthritis Res. Ther, vol.11, 2009.

S. D. Sullivan, The promise of specialty pharmaceuticals: are they worth the price?, J. Manag. Care Pharm, 2008.

Z. Sun, D. Unutmaz, Y. R. Zou, M. J. Sunshine, A. Pierani et al., Requirement for ROR? in thymocyte survival and lymphoid organ development, p.80, 2000.

R. Q. Thompson, Encyclopedia of Analytical Science, 2005.

A. ;. Tonshend and C. ). Poole, Journal of Chemical Education. Division of Chemical Education, p.1313

A. Trabandt, R. E. Gay, H. Birkedal-hansen, and S. Gay, Expression of collagenase and potential transcriptional factors in the MRL/l mouse arthropathy, Semin. Arthritis Rheum, vol.21, pp.246-51, 1992.

K. P. Trayes, J. S. Studdiford, S. Pickle, and A. S. Tully, Edema: Diagnosis and management, Am. Fam. Physician, vol.88, pp.102-110, 2013.

A. Van-campenhout and J. Golledge, Osteoprotegerin, vascular calcification and atherosclerosis, Atherosclerosis, vol.204, pp.321-329, 2009.

,

J. Van-roon, S. Wijngaarden, F. P. Lafeber, C. Damen, J. Van-de-winkel et al., Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation, J. Rheumatol, 2003.

T. L. Vincent, R. O. Williams, R. Maciewicz, A. Silman, P. Garside et al., Mapping pathogenesis of arthritis through small animal models, 2012.

J. P. Wang, Y. M. Zhou, Y. J. Ye, X. M. Shang, Y. L. Cai et al., Topical anti-inflammatory and analgesic activity of kirenol isolated from Siegesbeckia orientalis, J. Ethnopharmacol, vol.137, pp.1089-1094, 2011.
DOI : 10.1016/j.jep.2011.07.016

,

Q. Wang, X. Pan, H. H. Wong, C. A. Wagner, L. J. Lahey et al., Oral and topical boswellic acid attenuates mouse osteoarthritis, Osteoarthr. Cartil, vol.22, pp.128-132, 2014.
DOI : 10.1016/j.joca.2013.10.012
URL : https://doi.org/10.1016/j.joca.2013.10.012

S. Wang, Y. Wang, X. Liu, L. Guan, L. Yu et al., Anti-inflammatory and antiarthritic effects of taraxasterol on adjuvant-induced arthritis in rats, J. Ethnopharmacol, vol.187, pp.42-48, 2016.

Z. M. Wang, S. G. Zhu, Z. W. Wu, Y. Lu, H. Z. Fu et al., Kirenol upregulates nuclear Annexin-1 which interacts with NF-?B to attenuate synovial inflammation of collagen-induced arthritis in rats, J. Ethnopharmacol, vol.137, pp.774-782, 2011.

C. Wellbrock, M. Karasarides, and R. Marais, The RAF proteins take centre stage, Nat. Rev. Mol. Cell Biol, vol.5, pp.875-85, 2004.
DOI : 10.1038/nrm1498

T. Wen, W. Xu, L. Liang, J. Li, X. Ding et al., Clinical Efficacy of Andrographolide Sulfonate in the Treatment of Severe Hand, Foot, and Mouth Disease (HFMD) is Dependent upon Inhibition of Neutrophil Activation, Phyther. Res, 2015.

D. L. Wilhelm, Mechanisms responsible for increased vascular permeability in acute inflammation, Agents Actions, vol.3, pp.297-306, 1973.
DOI : 10.1007/bf01986484

Y. Xiong, Y. Ma, W. Han, N. D. Kodithuwakku, L. F. Liu et al., Clematichinenoside AR induces immunosuppression involving Treg cells in Peyers patches of rats with adjuvant induced arthritis, J. Ethnopharmacol, vol.155, pp.1306-1314, 2014.

J. Yue, D. Wu, and L. Tam, The role of imaging in early diagnosis and prevention of joint damage in inflammatory arthritis, Expert Rev. Clin. Immunol, vol.14, pp.499-511, 2018.

J. M. Zhang and J. An, Cytokines, inflammation, and pain, Int. Anesthesiol. Clin, 2007.
DOI : 10.1097/aia.0b013e318034194e
URL : http://europepmc.org/articles/pmc2785020?pdf=render

S. Zhang, G. Huang, K. Yuan, Q. Zhu, H. Sheng et al., Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities, Clin. Exp. Immunol, vol.190, pp.29-39, 2017.
DOI : 10.1111/cei.12993
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/cei.12993